Ono Pharmaceutical

Equillium to be included in the Russell Microcap® Index

Retrieved on: 
星期三, 六月 12, 2024
Biotechnology, Health, Genetics, Pharmaceutical, Clinical Trials, Partnership, Ono Pharmaceutical, Growth, Russell Microcap Index, Therapy, Pharmaceutical industry

The annual Russell reconstitution captures the 4,000 largest US stocks as of Tuesday, April 30, ranking them by total market capitalization.

Key Points: 
  • The annual Russell reconstitution captures the 4,000 largest US stocks as of Tuesday, April 30, ranking them by total market capitalization.
  • Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes.
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
  • “We’re happy to be joining the Russell Microcap Index, paving the way for potential inclusion in a large number of funds that aim to mimic and benchmark the Russell indices,” said Bruce Steel, chief executive officer at Equillium.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, AGS, DCPH

Retrieved on: 
星期四, 五月 30, 2024
Squarespace, Sale, Permira, Ono Pharmaceutical, Advertising, Fraud, Security (finance)

If you are a Squarespace shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Squarespace shareholder, click here to learn more about your rights and options .
  • Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK - RBAZ), Squarespace, Inc. (NYSE - SQSP), PlayAGS, Incorporated (NYSE - AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)

Retrieved on: 
星期四, 五月 30, 2024
AGS, Brodsky, Squarespace, Republic Bank, Permira, ONO, Ono Pharmaceutical, Security (finance)

BALA CYNWYD, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.

Key Points: 
  • BALA CYNWYD, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, AGS will be acquired by affiliates of Brightstar Capital Partners (“Brightstar”) for $12.50 per share in cash.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – DCPH, DPSI, AIRC, DRQ

Retrieved on: 
星期三, 五月 29, 2024
Aimco, Empire, AIRC, ONO, DRQ, AIR, Ono Pharmaceutical, Security (finance)

Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.

Key Points: 
  • Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.
  • DecisionPoint Systems, Inc. (NYSE: DPSI ), relating to its proposed merger with Barcoding Holdings, LLC, a portfolio company of Graham Partners.
  • Apartment Income REIT Corp. (NYSE: AIRC ), relating to its proposed merger with Blackstone Real Estate Partners X.
  • Dril-Quip, Inc. (NYSE: DRQ ), relating to its proposed merger with Innovex Downhole Solutions, Inc..

Equillium to Present at the Jefferies Global Healthcare Conference

Retrieved on: 
星期三, 五月 29, 2024
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Partnership, Therapy, Ono Pharmaceutical, Marriott Marquis, Conference

Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will present at the Jefferies Global Healthcare Conference taking place at the Marriott Marquis in New York, NY, June 4 – 6, 2024.

Key Points: 
  • Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will present at the Jefferies Global Healthcare Conference taking place at the Marriott Marquis in New York, NY, June 4 – 6, 2024.
  • Management will provide an overview of the company’s clinical programs – including EQ101 for the treatment for alopecia areata with data expected before the end of June 2024 – the company’s partnership with Ono Pharmaceutical, and 2024 milestones.
  • Management will also be available for one-on-one meetings during the conference.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK - RBAZ), Squarespace, Inc. (NYSE - SQSP), PlayAGS, Incorporated (NYSE - AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)

Retrieved on: 
星期一, 五月 20, 2024
AGS, Brodsky, Squarespace, Republic Bank, Permira, ONO, Ono Pharmaceutical, Security (finance)

BALA CYNWYD, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.

Key Points: 
  • BALA CYNWYD, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, AGS will be acquired by affiliates of Brightstar Capital Partners (“Brightstar”) for $12.50 per share in cash.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights

Retrieved on: 
星期四, 五月 9, 2024
FDA, Cancer, Ono Pharmaceutical, Poster, Research, ASCO, Autoimmune disease, Society, Inflammation, Clinical trial, Annual general meeting, Autoimmunity

BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells, today provided a business and financial update for the first quarter 2024.

Key Points: 
  • BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells, today provided a business and financial update for the first quarter 2024.
  • CUE-101 abstract accepted for an oral presentation and poster presentation at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting scheduled for May 31-June 4, 2024.
  • CUE-102 abstract accepted for a poster presentation at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting scheduled for May 31-June 4, 2024.
  • Advanced preclinical CUE-401 program, in collaboration with Ono Pharmaceutical, with potential for broad application across multiple autoimmune and inflammatory diseases.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HCP, TBNK

Retrieved on: 
星期四, 五月 9, 2024
Advertising, Sale, Fraud, Ono Pharmaceutical, IBM, HashiCorp, Security (finance)

If you are a HashiCorp shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a HashiCorp shareholder, click here to learn more about your rights and options .
  • Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: PlayAGS, Incorporated (NYSE - AGS), HashiCorp Inc. (Nasdaq - HCP), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH), Territorial Bancorp, Inc. (Nasdaq - TBNK)

Retrieved on: 
星期四, 五月 9, 2024
HOPE, HashiCorp, ONO, Ono Pharmaceutical, Brodsky, AGS, IBM, Security (finance)

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, HashiCorp will be acquired by IBM (NYSE – IBM).
  • IBM will acquire all outstanding shares of HashiCorp common stock for $35.00 per share in cash, for an enterprise value of $6.4 billion.
  • Under the terms of the agreement, Territorial Bancorp will be acquired by Hope Bancorp, Inc. (“Hope Bancorp”) (Nasdaq - HOPE).

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, DPSI, UNIT

Retrieved on: 
星期六, 五月 4, 2024
Sale, Advertising, UMB Financial Corporation, Ono Pharmaceutical, UNIT, UMB, Elliott Investment Management, Windstream Holdings, Fraud, Security (finance)

If you are a Deciphera shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Deciphera shareholder, click here to learn more about your rights and options .
  • DecisionPoint Systems, Inc. (NYSE: DPSI)’s sale to an affiliate of Barcoding Holdings, LLC for $10.22 in cash per share.
  • Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.